FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)

View source ↗

Summary

The FDA approved a supplemental application filed by Dr. Reddy's Laboratories Inc for clopidogrel bisulfate (generic) to support changes to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Artery Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Clopidogrel bisulfate (clopidogrel bisulfate)

Snippet

SUPPL AP for CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULFATE)